EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc

Li Jiang iD, Xuxin Qi, Minshan Lai, Jiahao Zhou iD, Meng Yuan, Jieqiong You, Qiang Liu, Jinchang Pan, Luyao Zhao, Meidan Ying, Junfang Ji, Ke Li und 5 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2407904121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Li Jiang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Institute of Pharmacology and Toxicology, Zhejiang…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proto-Oncogene Proteins c-myc, Cellular Senescence. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Youth Fund of the National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysfunction of the ubiquitin–proteasome system (UPS) facilitates the malignant progression of hepatocellular carcinoma (HCC). While targeting the UPS for HCC therapy has been proposed, identifying effective targets has been challenging. In this study, we conducted a focused screen of siRNA libraries targeting UPS-related WD40 repeat (WDR) proteins and found that silencing WDR20, a deubiquitinating enzyme activating factor, selectively inhibited the proliferation of HCC cells without affecting normal hepatocytes. Moreover, the downregulation of WDR20 expression induced HCC cellular senescence and suppressed tumor progression in xenograft, sleeping beauty transposon/transposase, and hydrodynamic tail vein injection-induced HCC models, and Alb-Cre + / MYC + HCC transgenic mouse models. Mechanistically, we found that WDR20 silencing disturbed the protein stability of c-Myc, orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc, thereby promoting the transcriptional activation of CDKN1A . Further investigation revealed a positive coexpression of WDR20 and c-Myc in a tissue microarray with 88 HCC clinical samples. By employing three patient-derived organoids from individuals with HCC, we have validated the decrease in c-Myc expression and the significant induction of senescence and growth inhibition following silencing of WDR20. This study not only uncovers the biological function of WDR20 and elucidates the molecular mechanism underlying its negative regulation of HCC cellular senescence but also highlight the potential of WDR20 as a promising target for HCC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsProto-Oncogene Proteins c-mycCellular SenescenceUbiquitinationUbiquitin ThiolesteraseHumansAnimalsMiceCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticMice, TransgenicCarrier Proteins

Stichwörter der Autor:innen

USP12/46WDR20c-Myccellular senescencehepatocellular carcinoma

Substanzen

Proto-Oncogene Proteins c-mycUbiquitin ThiolesteraseWDR20 protein, humanMYC protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Institute of Pharmacology and Toxicology, Zhejiang University, Hangzhou 310058, China.
  • The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310018, China.
  • Cancer Center, Zhejiang University, Hangzhou 310058, China.
  • Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.
  • Life Sciences Institute, Zhejiang University, Hangzhou 310058, China.
  • Key Laboratory of Biotechnology of Antibiotic of National Health Commission, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Li Jiang, Jiahao Zhou, Yan Zhang, Weiwei Pan, Ji Cao

Förderung

  • National Key R&D Program of China
  • Youth Fund of the National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • the Fundamental Research Funds for the Central Universities

Zitieren

APA

Jiang, L., Qi, X., Lai, M., Zhou, J., Yuan, M., You, J., Liu, Q., Pan, J., Zhao, L., Ying, M., Ji, J., Li, K., Zhang, Y., Pan, W., He, Q., Yang, B., & Cao, J. (2024). WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2407904121

Vancouver

Jiang L, Qi X, Lai M, Zhou J, Yuan M, You J, et al. WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2407904121

BibTeX
@article{Jiang2024,
  author = {Jiang, Li and Qi, Xuxin and Lai, Minshan and Zhou, Jiahao and Yuan, Meng and You, Jieqiong and Liu, Qiang and Pan, Jinchang and Zhao, Luyao and Ying, Meidan and Ji, Junfang and Li, Ke and Zhang, Yan and Pan, Weiwei and He, Qiaojun and Yang, Bo and Cao, Ji},
  title = {WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2407904121}
}
Kostenlos starten →